Follow
Jean-Baptiste Dupont
Jean-Baptiste Dupont
ATIP Avenir Group Leader INSERM UMR 1089
Verified email at univ-nantes.fr - Homepage
Title
Cited by
Cited by
Year
Advanced characterization of DNA molecules in rAAV vector preparations by single-stranded virus next-generation sequencing
E Lecomte, B Tournaire, B Cogné, JB Dupont, P Lindenbaum, ...
Molecular Therapy-Nucleic Acids 4, 2015
772015
Myogenesis modelled by human pluripotent stem cells: a multi‐omic study of Duchenne myopathy early onset
V Mournetas, E Massouridès, JB Dupont, E Kornobis, H Polvèche, ...
Journal of cachexia, sarcopenia and muscle 12 (1), 209-232, 2021
332021
AAV-mediated gene transfer restores a normal muscle transcriptome in a canine model of X-linked myotubular myopathy
JB Dupont, J Guo, E Renaud-Gabardos, K Poulard, V Latournerie, ...
Molecular Therapy 28 (2), 382-393, 2020
252020
Short-lived recombinant adeno-associated virus transgene expression in dystrophic muscle is associated with oxidative damage to transgene mRNA
JB Dupont, B Tournaire, C Georger, B Marolleau, L Jeanson-Leh, ...
Molecular Therapy Methods & Clinical Development 2, 2015
232015
NGS library preparation may generate artifactual integration sites of AAV vectors
B Cogné, R Snyder, P Lindenbaum, JB Dupont, R Redon, P Moullier, ...
Nature Medicine 20 (6), 577-578, 2014
192014
CRISPR gene editing in pluripotent stem cells reveals the function of MBNL proteins during human in vitro myogenesis
A Mérien, J Tahraoui-Bories, M Cailleret, JB Dupont, C Leteur, J Polentes, ...
Human molecular genetics 31 (1), 41-56, 2022
172022
Voluntary wheel running complements microdystrophin gene therapy to improve muscle function in mdx mice
SE Hamm, DD Fathalikhani, KE Bukovec, AK Addington, H Zhang, ...
Molecular Therapy-Methods & Clinical Development 21, 144-160, 2021
152021
High-throughput, real-time monitoring of engineered skeletal muscle function using magnetic sensing
AST Smith, SM Luttrell, JB Dupont, K Gray, D Lih, JW Fleming, ...
Journal of tissue engineering 13, 20417314221122127, 2022
122022
Restriction factors against recombinant adeno-associated virus vectormediated gene transfer in dystrophin-deficient muscles
JB Dupont
Current Gene Therapy 16 (3), 168-183, 2016
32016
Rétrovirus humain XMRV: la fin d'une histoire séduisante
S Assil, PA Bolze, M Boukhali, C Cariou, L Chauveau, N Chuvin, ...
Virologie 15 (4), 222-34, 2011
32011
Myogenesis modelled by human pluripotent stem cells uncovers duchenne muscular dystrophy phenotypes prior to skeletal muscle commitment
V Mournetas, E Massouridès, JB Dupont, E Kornobis, H Polvèche, ...
BioRxiv, 720920, 2019
22019
Gene Therapy for X-Linked Myotubular Myopathy
JB Dupont, MW Lawlor, MK Childers
Muscle Gene Therapy, 565-577, 2019
12019
Transcriptomic Analysis Reveals the Inability of Recombinant AAV8 to Activate Human Monocyte-Derived Dendritic Cells
S Masri, L Carré, N Jaulin, C Vandamme, C Couzinié, A Guy-Duché, ...
International Journal of Molecular Sciences 24 (13), 10447, 2023
2023
Dystrophin deficiency impairs cell junction formation during embryonic myogenesis
E Mozin, E Massouridès, V Mournetas, C Lièvre, A Bourdon, DL Jackson, ...
bioRxiv, 2023.12. 05.569919, 2023
2023
Intramuscular delivery of rAAV in non-human primates results in a chronic local inflammation in situ without the loss of transgene expression
M Journou, M Guilbaud, M Devaux, N Jaulin, JB Dupont, G Gernoux, ...
HUMAN GENE THERAPY 32 (19-20), A27-A27, 2021
2021
Genetic diseases in the omics era
JB Dupont
Molecular Therapy 29 (8), 2389-2390, 2021
2021
AAV Intramuscular Gene Transfer in the Non-Human Primate Model Leads to an In Situ Immune Transcriptomic Signature
M Journou, M Guilbaud, M Devaux, N Jaulin, JB Dupont, V Pichard, ...
MOLECULAR THERAPY 29 (4), 353-353, 2021
2021
LATE BREAKING NEWS E-POSTER PRESENTATION: LBP 4 Novel Epigenetic Small Molecule Approaches and Single-Cell Epigenetic Analysis for DMD
L Maves, JB Dupont, GH Farr, S Luttrell, M Morris, A Gomez, T Pham, ...
Neuromuscular Disorders 30, S168, 2020
2020
Improvement of pluripotent stem cell-derived skeletal muscle myotube maturation through the combination of physical and chemical factors
JB Dupont, E Massourides, V Mournetas, SM Luttrell, DL Mack, C Pinset
HUMAN GENE THERAPY 30 (11), A131-A132, 2019
2019
Single cell developmental trajectories reveal early phenotypes in Duchenne muscular dystrophy prior to skeletal muscle commitment
JB Dupont, SM Luttrell, D Jackson, JS Packer, L Maves, C Trapnell, ...
HUMAN GENE THERAPY 30 (11), A123-A123, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20